Takeshi Hisamatsu
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Inflammatory Biomarkers in Disease Prognosis, RNA modifications and cancer, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Uterine Cervical Cancer Displaying Tumor-Related Leukocytosis: A Distinct Clinical Entity With Radioresistant Feature(2014)129 cited
- → Role of ADP receptors on platelets in the growth of ovarian cancer(2017)113 cited
- → Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer(2017)103 cited
- → Therapeutic Silencing of KRAS Using Systemically Delivered siRNAs(2014)95 cited
- → miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression(2013)95 cited
- → Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma(2015)56 cited
- → Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: A monoinstitutional study(2015)51 cited
- → Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)(2017)50 cited
- → XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A(2015)45 cited
- → Potential Role of mTORC2 as a Therapeutic Target in Clear Cell Carcinoma of the Ovary(2013)40 cited